Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy.

TitleLiposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy.
Publication TypeJournal Article
Year of Publication2021
AuthorsChu, CE, Law, L, Zuniga, K, Lin, TKuo, Tsourounis, C, Rodriguez-Monguio, R, Lazar, A, Washington, SL, Cooperberg, MR, Greene, KL, Carroll, PR, Pruthi, RS, Meng, MV, Chen, L-L, Porten, SP
JournalUrology
Volume149
Pagination168-173
Date Published2021 Mar
ISSN1527-9995
KeywordsAged, Analgesia, Epidural, Analgesics, Opioid, Anesthetics, Local, Bupivacaine, Cystectomy, Female, Humans, Length of Stay, Male, Middle Aged, Opioid-Related Disorders, Pain Management, Pain Measurement, Pain, Postoperative, Retrospective Studies, Treatment Outcome, Urinary Diversion
Abstract

OBJECTIVE: To analyze differences in length of stay, opioid use, and other perioperative outcomes in patients undergoing radical cystectomy with urinary diversion who received either liposomal bupivacaine (LB) or epidural analgesia.

METHODS: This was a single center, retrospective cohort study of patients undergoing open radical cystectomy with urinary diversion from 2015-2019 in the early recovery after surgery (ERAS) pathway. Patients received either LB or epidural catheter analgesia for post-operative pain control. LB was injected at the time of fascial closure to provide up to 72 hours of local analgesia. The primary outcome was post-operative length of stay. Secondary outcomes were post-operative opioid use, time to solid food, time to ambulation, and direct hospitalization costs. Multivariable Cox proportional hazards regression was used to determine associations between analgesia type and discharge.

RESULTS: LB use was independently associated with shorter post-operative length of stay compared to epidural use (median (IQR) 4.9 days (3.9-5.8) vs 5.9 days (4.9-7.9), P<.001), less total opioid use (mean 188.3 vs 612.2 OME, P <.001), earlier diet advancement (mean 1.6 vs 2.4 days, P <.001), and decreased overall direct costs ($23,188 vs $29,628, P <.001). 45% of patients who received LB were opioid-free after surgery, none in the epidural group. On multivariable Cox proportional hazards regression modeling, LB use was independently associated with earlier discharge (HR 2.1, IQR 1.0-4.5).

CONCLUSION: Use of LB in open radical cystectomy is associated with reduced LOS, less opioid exposure, and earlier diet advancement.
DOI10.1016/j.urology.2020.11.036
Alternate JournalUrology
PubMed ID33278460